The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 02, 2010
Filed:
Jan. 10, 2008
Marcel Patek, Tucson, AZ (US);
Anil Nair, Tucson, AZ (US);
Augustin Hittinger, Igny, FR;
Conception Nemecek, Thiais, FR;
Daniel Bond, Tucson, AZ (US);
Greg Harlow, Boulder, CO (US);
Herve Bouchard, Thiais, FR;
Jacques Mauger, Tucson, AZ (US);
Jean-luc Malleron, Marcoussis, FR;
Mark Palermo, Rindge, NH (US);
Fahad Al-obeidi, Tucson, AZ (US);
Thomas Faitg, Exton, PA (US);
Hartmut Strobel, Liederbach, DE;
Sven Ruf, Floersheim, DE;
Kurt Ritter, Frankfurt Am Main, DE;
Youssef El-ahmad, Creteil, FR;
Dominique Lesuisse, Montreuil, FR;
Didier Bénard, Attainville, FR;
Marcel Patek, Tucson, AZ (US);
Anil Nair, Tucson, AZ (US);
Augustin Hittinger, Igny, FR;
Conception Nemecek, Thiais, FR;
Daniel Bond, Tucson, AZ (US);
Greg Harlow, Boulder, CO (US);
Herve Bouchard, Thiais, FR;
Jacques Mauger, Tucson, AZ (US);
Jean-Luc Malleron, Marcoussis, FR;
Mark Palermo, Rindge, NH (US);
Fahad Al-Obeidi, Tucson, AZ (US);
Thomas Faitg, Exton, PA (US);
Hartmut Strobel, Liederbach, DE;
Sven Ruf, Floersheim, DE;
Kurt Ritter, Frankfurt Am Main, DE;
Youssef El-Ahmad, Creteil, FR;
Dominique Lesuisse, Montreuil, FR;
Didier Bénard, Attainville, FR;
Aventis Pharma S.A., Antony, FR;
Abstract
The disclosure relates to a cyclic urea compound of formula I: as defined herein, to the process for its preparation, pharmaceutical composition comprising it and its pharmaceutical use as an inhibitor on a protein kinase. Thus, the compound of formula I is useful for preventing or treating a physiological disorder capable of being modulated by inhibiting the activity of a protein kinase, such as a solid tumor.